<DOC>
	<DOCNO>NCT00902902</DOCNO>
	<brief_summary>The aim study divide three part : 1 . To evaluate sensitivity specificity GP73 diagnosis hepatitis B related HCC . Established standard GP73 normal people . 2 . To definitude connection GP73 level various disease . 3 . To find relation HCC metastasis recurrence . Study design : 1 . Collectivity type : Prospectiveï¼Œrandomized , control , multi-central clinical study . 2 . Patients : The subject different hospital include : Peking Union Medical College Hospital ( PUMCH ) , The Cancer Hospital Peking Union Medical College ( PUMC ) , QiDong Cancer Institute , Department Surgery University Chicago November 2007 till end study . Study arrangement : This study consist three part : 1 . Established standard normal people test sensitivity specificity HCC patient . The sample acquire Health Screen Center Department liver surgery PUMCH , The Cancer Hospital PUMC QiDong Cancer Institute . 2 . Extend study bound , include hepatitis B virus ( HBV ) hepatitis C virus ( HCV ) carrier . The HBV ( + ) sample come Chinese hospital institution . The HCV ( + ) sample provide Department Surgery University Chicago . 3 . Research relation serum GP73 level disease , malignant liver tumor , liver metastatic tumor , liver benign tumor , HCC recurrence follow surgery etc .</brief_summary>
	<brief_title>A Clinical Study GP73 Hepatocellular Carcinoma ( HCC ) Tumor Mark</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>A group patient history liver disease , alcohol consumption le 40g week , risk factor viral hepatitis enrol General Internal Medicine clinic . All subject control group document normal liver biochemistry . Consecutive patient HCC patient HBV &amp; HCV age , gender , race/ethnicity match HCC patient enrol Liver Clinic period . The diagnosis HCC make histopathology , histopathology available two image modality ( ultrasound [ US ] , magnetic resonance image [ MRI ] , compute tomography ) show vascular enhance mass &gt; 2cm . HBV infection status base hepatitis B surface antigen ( HBsAg ) . HCV infection status base serum HCV antibody HCVRNA positive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Hepatocellular carcinoma</keyword>
</DOC>